Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Drug Conjugation via Maleimide-Thiol Chemistry Does Not Affect Targeting Properties of Cysteine-Containing Anti-FGFR1 Peptibodies.
Mol Pharm. 2022 May 2;19(5):1422-1433. doi: 10.1021/acs.molpharmaceut.1c00946. Epub 2022 Apr 7.
Mol Pharm. 2022.
PMID: 35389227
Free PMC article.
Peptibody Based on FGFR1-Binding Peptides From the FGF4 Sequence as a Cancer-Targeting Agent.
Jendryczko K, Rzeszotko J, Krzyscik MA, Szymczyk J, Otlewski J, Szlachcic A.
Jendryczko K, et al. Among authors: rzeszotko j.
Front Pharmacol. 2021 Nov 12;12:748936. doi: 10.3389/fphar.2021.748936. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34867353
Free PMC article.
Item in Clipboard
FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1.
Jendryczko K, Chudzian J, Skinder N, Opaliński Ł, Rzeszótko J, Wiedlocha A, Otlewski J, Szlachcic A.
Jendryczko K, et al. Among authors: rzeszotko j.
Cancers (Basel). 2020 Oct 15;12(10):2992. doi: 10.3390/cancers12102992.
Cancers (Basel). 2020.
PMID: 33076489
Free PMC article.
Item in Clipboard
Cite
Cite